PI3K/AKT/mTOR signaling pathway in breast cancer: from molecular landscape to clinical aspects
Breast cancer is a serious health problem worldwide, representing the second cause of
death through malignancies among women in developed countries. Population …
death through malignancies among women in developed countries. Population …
RETRACTED ARTICLE: Roles of the PI3K/AKT/mTOR signalling pathways in neurodegenerative diseases and tumours
F Xu, L Na, Y Li, L Chen - Cell & bioscience, 2020 - Springer
Abstract The PI3 K/AKT/mTOR signalling pathway plays an important role in the regulation of
signal transduction and biological processes such as cell proliferation, apoptosis …
signal transduction and biological processes such as cell proliferation, apoptosis …
The pathogenic role of PI3K/AKT pathway in cancer onset and drug resistance: an updated review
F Rascio, F Spadaccino, MT Rocchetti, G Castellano… - Cancers, 2021 - mdpi.com
Simple Summary Drug resistance remains one of the major problems in cancer therapy and
is responsible for up to 90% of cancer-related deaths. It exists across all types of cancer and …
is responsible for up to 90% of cancer-related deaths. It exists across all types of cancer and …
Targeting the PI3K/AKT/mTOR signaling pathway in the treatment of human diseases: Current status, trends, and solutions
J Huang, L Chen, J Wu, D Ai, JQ Zhang… - Journal of medicinal …, 2022 - ACS Publications
The phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of
rapamycin (mTOR) pathway is one of the most important intracellular pathways involved in …
rapamycin (mTOR) pathway is one of the most important intracellular pathways involved in …
Mitochondria quality control and male fertility
Simple Summary Mitochondria play a crucial role in numerous cellular processes, including
energy production, apoptosis, and calcium homeostasis. In the male reproductive system …
energy production, apoptosis, and calcium homeostasis. In the male reproductive system …
Elevated PDK1 expression drives PI3K/AKT/MTOR signaling promotes radiation-resistant and dedifferentiated phenotype of hepatocellular carcinoma
OA Bamodu, HL Chang, JR Ong, WH Lee, CT Yeh… - Cells, 2020 - mdpi.com
Resistance to radiotherapy (IR), with consequent disease recurrence, continues to limit the
efficacy of contemporary anticancer treatment for patients with hepatocellular carcinoma …
efficacy of contemporary anticancer treatment for patients with hepatocellular carcinoma …
Causes and consequences of sperm mitochondrial dysfunction
D Durairajanayagam, D Singh, A Agarwal… - Andrologia, 2021 - Wiley Online Library
Mitochondria have multiple functions, including synthesis of adenine triphosphate,
production of reactive oxygen species, calcium signalling, thermogenesis and apoptosis …
production of reactive oxygen species, calcium signalling, thermogenesis and apoptosis …
Akt isoforms in the immune system
M Guerau-de-Arellano, ZL Piedra-Quintero… - Frontiers in …, 2022 - frontiersin.org
Akt is a PI3K-activated serine-threonine kinase that exists in three distinct isoforms. Akt's
expression in most immune cells, either at baseline or upon activation, reflects its …
expression in most immune cells, either at baseline or upon activation, reflects its …
Akt-ing up just about everywhere: compartment-specific Akt activation and function in receptor tyrosine kinase signaling
The serine/threonine kinase Akt is a master regulator of many diverse cellular functions,
including survival, growth, metabolism, migration, and differentiation. Receptor tyrosine …
including survival, growth, metabolism, migration, and differentiation. Receptor tyrosine …
MDM2 antagonists overcome intrinsic resistance to CDK4/6 inhibition by inducing p21
AE Vilgelm, N Saleh, R Shattuck-Brandt… - Science translational …, 2019 - science.org
Intrinsic resistance of unknown mechanism impedes the clinical utility of inhibitors of cyclin-
dependent kinases 4 and 6 (CDK4/6i) in malignancies other than breast cancer. Here, we …
dependent kinases 4 and 6 (CDK4/6i) in malignancies other than breast cancer. Here, we …